In AU, the 750mcg parathyroid hormone vial is presently accessible through limited channels, typically subject to special authorization . Distribution of this stronger formulation has been moderately constrained due to its price , rigorous prescribing criteria , and the continued need for counselling regarding its use and potential risks. Prescribe